Bone Marrow Aspiration and Biopsy in Suspected Blood Cancer

Bone marrow sampling is a targeted procedure for selected unexplained blood abnormalities or suspected hematopoietic cancer, not a routine test for every tumor.

An aspirate evaluates individual marrow cells, while a core biopsy preserves architecture. The samples answer different questions and may be paired with cytology, histopathology, flow cytometry, molecular tests, cultures, or special stains.

The procedure may help distinguish marrow neoplasia, infiltration, dysplasia, immune destruction, infection, or suppressed cell production when CBC and smear findings do not provide enough information.

Its value is highest when the result answers a defined question and would change diagnosis, staging, treatment, anesthesia, supportive care, or the recheck plan. Testing without a decision pathway can add cost or uncertainty without helping the patient.

The veterinary team selects timing, sample type, preparation, laboratory or imaging method, and repetition interval for the individual patient. Ask how this result will be interpreted alongside examination findings, pathology, prior results, medicines, and current symptoms.

Bone marrow evaluation is an established specialized diagnostic method. Yield depends on selecting the right indication, site, samples, and ancillary tests; a nondiagnostic or focal sample does not exclude every marrow disorder.

Sedation or anesthesia, pain, bruising, bleeding, infection, and a dry or inadequate sample are possible. Platelet status, anatomy, patient stability, and the plan for each specimen should be reviewed in advance.

A normal result cannot rule out every tumor or complication, and an abnormal result does not by itself identify the cause. Collection quality, timing, prior treatment, sedation, and laboratory or operator variation can affect interpretation.